AstraZeneca's SGLT2 inhibitor Farxiga has hit the mark in a phase 3 heart failure trial that brings it back into contention with its main rival Jardiance from Boehringer Ingelheim and Eli Lilly.

Investments aren’t just numbers—they’re stories, and you can tell those stories with Presentation Studio. This Morningstar Direct module lets you use Morningstar data and analytics to distill complex ...

D3-AM GmbH has delivered a LAB II ceramic 3D printing system to a customer in Germany, positioning the company for closer cooperation in the region. The company characterizes the installation as the ...

This repository provides a LaTeX template for IEEE-style papers, including proper formatting, section structures, bibliography management, and example content. It is designed to be used for conference ...

Built for uni students, STEM grads, and software engineers. Showcase real projects, ship a clean blog, and stand out with a modern dark-first design — without a fragile “black box” React app.

Background Coronary artery aneurysms (CAA) are rare vascular abnormalities defined as focal dilations exceeding 1.5 times the diameter of an adjacent normal segment. The leading cause of CAAs in ...